Reviews Urofollitropin Injection


No reviews yet.

Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008





Other reviews about Urofollitropin Injection on wordpress

fertility
  by as71kumar
Boosting fertility Every couple has a common dream of having a nice child after marriage. Almost every woman wants to be a mother at least once in a lifetime.  […]



Other reviews about Urofollitropin Injection on web:

Consumer information about the medication UROFOLLITROPIN - SUBCUTANEOUS INJECTION (Bravelle, Fertinex, Follistim, Gonal-F), includes side effects, drug interactions, recommended ... UROFOLLITROPIN - SUBCUTANEOUS INJECTION (Bravelle, Fertinex ...


Urofollitropin, FSH Injection To return to the main entry click here . What is Urofollitropin, FSH Injection? UROFOLLITROPIN (Bravelle™, Urofollitropin, FSH Injection: Information from Answers.com


Consumer information about the medication UROFOLLITROPIN - INJECTION (Metrodin), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... UROFOLLITROPIN - INJECTION (Metrodin) side effects, medical uses ...


Urofollitropin, FSH Brand names: Bravelle™Fertinex™ Drug Forms: Urofollitropin, FSH Injection (below) Urofollitropin (FSH) Solution for urofollitropin: Definition from Answers.com


Any urofollitropin that has been prepared for injection (mixed in the syringe) should be used right away. Throw away any unused medicine. Keep all medicine out of the reach of ... St. Luke's Sugar Land Hospital - Your Health Topics


Any urofollitropin that has been prepared for injection (mixed in the syringe) should be used right away. Throw away any unused medicine. Keep all medicine out of the reach of ... Kelsey-Seybold Clinic - Welcome


Urofollitropin, Injection yoor-oh-fol-li-TROH-pin What are other names for this medicine? Type of medicine: gonadotropin; infertility therapy; ovulation stimulator CRS Topic


Learn all about Urofollitropin (Injection). Urofollitropin (ure-oh-FOL-li-troe-pin) Causes the ovaries to release eggs (ovulation) in women who have polycystic ovary disease or a ... Urofollitropin (Injection) - Drug Information


Any urofollitropin that has been prepared for injection (mixed in the syringe) should be used right away. Throw away any unused medicine. Keep all medicine out of the reach of ... Health Library


Urofollitropin (Injection): Urofollitropin (ure-oh-FOL-li-troe-pin)Causes the ovaries to release eggs (ovulation) in women who have polycystic ovary disease or a hormone problem ... Urofollitropin (Injection)





Featured Reviews

Reviews Creon

Creon Drug Description CREON (pancrelipase) Delayed-Release Capsules DRUG DESCRIPTION What are the possible side effects of pancrelipase? Get emergency medical help if you have any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Saquinavir Mesylate

Invirase Drug Description INVIRASE® (saquinavir mesylate) Capsules and Tablets Product identification in this document includes: INVIRASE in reference to saquinavir mesylate; saquinavir soft gel capsules in reference to saquinavir ...
Read More  |  Review This
Reviews Genoptic

Genoptic Drug Description DRUG DESCRIPTIONGENOPTIC® (gentamicin sulfate ophthalmic solution; USP) is a sterile, topical anti-infective agent for ophthalmic use. The active ingredient, gentamicin sulfate, is a water-soluble antibiotic...
Read More  |  Review This
Reviews Septra

Septra Drug Description Septra Tablets (trimethoprim and sulfamethoxazole) Tablets Septra DS Tablets (trimethoprim and sulfamethoxazole) DS Tablets Septra Suspension (trimethoprim and sulfamethoxazole) Suspension Septra Grape...
Read More  |  Review This
Reviews Leuprolide Acetate Implant

Viadur Drug Description Viadur® (leuprolide acetate) Implant DRUG DESCRIPTION Viadur® (leuprolide acetate implant) is a sterile nonbiodegradable, osmotically driven miniaturized implant designed to deliver leuprolide acetate for...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....